Take the Free Diagnostic

Treatment Foundations of Oncology

CPR APPLICATIONS FOUNDATION · CHAPTER 11 · TREATMENT

Treatment Foundations of Oncology

Organize the chapter before drilling into individual CPR concepts.

Supplemental foundation map: this page orients the detailed CPR Applications for Chapter 11. It is not part of the canonical CPR object inventory.

Browse the Foundations Library

Move through Chapter 11

Normal Foundations

Open normal foundations →

Abnormal Foundations

Open abnormal foundations →

Treatment Foundations · You are here

Open treatment foundations →

11.23 · SOURCE CPR FOUNDATION

Concept

Oncology treatment is mechanism plus toxicity recognition. Cytotoxic drugs broadly injure dividing cells, while targeted therapies disrupt specific oncogenic dependencies. The correct Step 1 move is identifying the cellular process being blocked and predicting collateral injury.

Pattern

Step 1 treatment stems often ask which mechanism matches a drug class or why a new complication developed after therapy. Marrow suppression is common with many cytotoxic regimens, but not all agents cause equivalent myelosuppression. Signature toxicities like heart failure or neuropathy narrow the class when the stem provides organ-specific clues.

Rule

  1. Identify what process is blocked. DNA damage, DNA synthesis, mitosis, signaling, or immune checkpoint regulation.
  2. Separate cytotoxic from targeted therapy. Broad cytotoxicity injures high-turnover tissues; targeted therapy follows pathway dependence.
  3. Predict normal-tissue toxicity. Marrow, mucosa, heart, nerves, and immune tissues are common targets.

Applications

  • Cytotoxic chemo pancytopenia → marrow suppression
  • Chemo mucositis → high-turnover tissue injury
  • New heart failure after chemo → cardiotoxicity clue
  • New neuropathy during cancer therapy → consider a neurotoxic agent such as a vinca alkaloid or taxane, along with other etiologies
  • Tip: Mechanism first, toxicity second

CPR APPLICATIONS · ACTIVE REASONING

Pair therapy with vulnerability

Make a prediction first. Each worked answer is available without JavaScript. These exercises do not save or send responses.

Decision 1: A broadly cytotoxic agent injures proliferating cells. Which normal tissue is at risk?

Worked reasoning and transfer

Best answer: Bone marrow and mucosa. Many cytotoxic agents affect rapid-turnover tissue.

Transfer: How does a targeted inhibitor alter risk?

Decision 2: A tumor is driven by BCR::ABL1 kinase. What target is appropriate?

Worked reasoning and transfer

Best answer: Fusion tyrosine kinase inhibition. Kinase inhibition may interrupt driver signaling.

Transfer: What might confer resistance?

Decision 3: Left ventricular dysfunction develops during certain cancer treatments. What is considered?

Worked reasoning and transfer

Best answer: Treatment-associated cardiotoxicity. Some anthracyclines and HER2-directed therapies cause cardiotoxicity.

Transfer: Why compare baseline cardiac function?

Explain it back: Write a causal chain for one decision, then identify which piece of evidence would change the answer.

Unscored teaching examples; not validated assessment items or patient-specific advice.

How to use this foundation map

  1. Identify the organizing mechanism.
  2. Recognize the pattern.
  3. Restate the rule without looking.
  4. Test transfer with applications and question practice.

Pair CPR with the 5P Approach™ when solving cases and questions.

Back to Chapter 11 in the Foundations Library · USMLE Step 1 resources